ReviewNeurology international2022
Novel Designer Benzodiazepines: Comprehensive Review of Evolving Clinical and Adverse Effects.
Review in Neurology international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 51 citations in OpenAlex.
- Global emergence and γ-aminobutyric acid type A (GABAArchives of toxicology · 2026Article
- Eco-Friendly Access to Indenodiazepinones fromACS medicinal chemistry letters · 2026Article
- The 1,5-Benzodiazepin-2-Ones: A Review on Synthetic Strategies, Reactivity and Functional Applications.Molecules (Basel, Switzerland) · 2026Review
- Determination of specific absorbance (A¦) for four designer benzodiazepines.Journal of analytical toxicology · 2026Article
- In vitro γ-aminobutyric acid A (GABACommunications chemistry · 2026Article
- Synergistic Effect ofPharmaceuticals (Basel, Switzerland) · 2026Article
- The Emergence of Novel Benzodiazepines in Australia, Evidence, Alerts, Clinical Management and Harm Reduction-A Narrative Review.Drug and alcohol review · 2026Review
- Characterizing trends and patterns in benzodiazepine-related toxicity deaths in Ontario: A descriptive cross-sectional study.PloS one · 2026Article
- Solvent-induced photophysical properties and stability of clonazepam and Chlordiazepoxide.Scientific reports · 2025Article
- Novel neurotherapeutic targets for substance use disorders: Neuroplasticity, neuroinflammation, gasotransmitters and non-canonical organ systems.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025Review
- New psychoactive substances: a multidisciplinary review of challenges and their diverse character.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2025Review
- Changes over time in novel benzodiazepines contributing to fatal overdoses in Victoria, Australia.Drug and alcohol review · 2025Article
- Forensic toxicology of benzodiazepines: neuropharmacological effects, analytical challenges, and emerging detection strategies.Frontiers in toxicology · 2025Review
- SIADH and mixed delirium following the abrupt cessation of long-acting benzodiazepines: a case report.Oxford medical case reports · 2024Article
- Fake Xanax: Designer Emerging Benzodiazepine Epidemic Linked to Morbidity and Mortality a Narrative Review.Neurology and therapy · 2024Review
- Benzodiazepine Boom: Tracking Etizolam, Pyrazolam, and Flubromazepam from Pre-UK Psychoactive Act 2016 to Present Using Analytical and Social Listening Techniques.Pharmacy (Basel, Switzerland) · 2024Article
- Article
- Add-On Treatment withPharmaceuticals (Basel, Switzerland) · 2023Article
- New Psychoactive Substances Intoxications and Fatalities during the COVID-19 Epidemic.Biology · 2023Review
- Benzodiazepines in Alzheimer's disease: beneficial or detrimental effects.Inflammopharmacology · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As tranquilizers, benzodiazepines have a wide range of clinical uses. Recently, there has been a significant rise in the number of novel psychoactive substances, including designer benzodiazepines. Flubromazolam(8-bromo-6-(2-fluorophenyl)-1-methyl-4
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.